Brief Enhanced Anxiety Sensitivity Treatment for Anxiety Disorders
(BEAST Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byNicholas P Allan, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: VA Office of Research and Development

No Placebo Group

Trial Summary

What is the purpose of this trial?

This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

Research Team

Nicholas P Allan, PhD

Principal Investigator

VA Finger Lakes Healthcare System, Canandaigua, NY

Eligibility Criteria

This trial is for English-speaking Veterans with high anxiety sensitivity and functional impairment, as indicated by specific scores on the SSASI and WHODAS 2.0 tests. It's not for those with severe schizophrenia, active psychosis or mania, immediate suicide risk, no smartphone access, or significant cognitive impairment.

Inclusion Criteria

Score equal to or greater than 5 on the WHODAS 2.0

I speak English.

Score equal to or greater than 9 on the SSASI indicating elevated anxiety sensitivity

Exclusion Criteria

I do not have severe mental health issues that would prevent me from participating.

Veterans with cognitive impairment as measured scoring equal to or greater than 11 on the Blessed Orientation-Memory-Concentration Test

Veterans without access to a smartphone

Treatment Details

Interventions

Brief Enhanced Anxiety Sensitivity Treatment (Behavioral Intervention)

Trial OverviewThe BEAST pilot study is evaluating a short-term treatment designed to lower anxiety sensitivity and improve daily functioning in Veterans. The focus is on how well participants accept this treatment and how practical it is to use.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: BEAST ConditionExperimental Treatment1 Intervention

A one-session intervention that can be delivered effectively by a clinician via telehealth and supplemented with a mobile app to provide opportunities to practice the skills learned in the face-to-face session.